Imprinted M6p/Igf2 receptor is mutated in rat liver tumors

J J Mills1, J G Falls, A T De Souza

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Oncogene
|July 4, 1998
PubMed

Insights

Inactivation of the mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) is crucial in liver cancer. This study shows M6P/IGF2R is imprinted in rats and mutated in rat liver tumors, supporting its tumor suppressor role.

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) inactivation is an early event in human liver and breast cancer.
  • M6P/IGF2R is imprinted in mice but biallelically expressed in most humans.

Purpose of the Study:

  • To investigate M6P/IGF2R imprinting in rat liver.
  • To identify mutations in the expressed M6P/IGF2R allele in rat liver tumors.

Main Methods:

  • Analysis of M6P/IGF2R imprinting in rat liver.
  • Mutation analysis of the expressed M6P/IGF2R allele in diethylnitrosamine-initiated rat liver tumors.

Main Results:

  • M6P/IGF2R is imprinted in the liver of Fischer 344, Lewis, and Brown Norway rats.
  • Mutations were identified in 40% of the expressed M6P/IGF2R alleles in rat liver tumors.

Conclusions:

  • These findings provide further evidence for M6P/IGF2R acting as a liver tumor suppressor gene.
  • Mice and rats may be more sensitive to certain hepatocarcinogens due to M6P/IGF2R imprinting.

Related Concept Videos